Chris Kryder
Executive Partner @ Flare Capital Partners
Jersey City, United States
Chris Kryder is a startup investor at Flare Capital Partners in Jersey City. Dr. Chris Kryder is a proven leader in today’s healthcare information technology arena. Chris served as chairman of Valence Health from 2012 until its acquisition by Evolent Health (NYSE:EVH) in 2016. Previously, he founded and grew D2Hawkeye, selling the company to ISO, which merged its health care Information technology assets to form VeriskHealth. He continued to lead the company after it went public as Verisk Analytics (NASDAQ:VRSK). He also co-founded Generation Health, the first Genetic-testing Benefits Manager (GBM), which was later sold to CVS Caremark.Chris earned his B.A. from the University of Buffalo, his M.D. from Georgetown University, and his MBA from the Massachusetts Institute of Technology. He completed his internal medicine (primary care) medical residency at Harvard, and maintained his primary care medical practice at MIT until the late 1990s. He has been active on the faculty of Harvard Medical School, Division of Health, Science, and Technology for more than 25 years.
Last updated:
For AI agents: llms.txt
About Flare Capital Partners
Flare Capital Partners provides capital for early-stage and emerging healthcare technology companies. The firm invests across the United States, recognizing that healthcare technology innovation is occurring in many cities around the country.
Flare Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Thomas Mac Mahon
Executive Partner
|
|||
Adam Bruce
Chief Financial Officer and Partner
|
|||
Bill Geary
Executive Partner Advisor
|
|||
|
Carter Prince
Flare Scholar
|
|||
|
Chris Kryder
Executive Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
